Por favor, use este identificador para citar o enlazar a este item:
http://hdl.handle.net/10261/124283
COMPARTIR / EXPORTAR:
SHARE CORE BASE | |
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE | |
Título: | In vivo siRNA delivery of Keap1 modulates death and survival signaling pathways and attenuates concanavalin-A-induced acute liver injury in mice |
Autor: | González-Rodríguez, Águeda CSIC ORCID; Reibert, Bjorn; Amann, Thomas; Constien, Rainier; Rondinone, Cristina M.; Valverde, Ángela M. CSIC ORCID | Fecha de publicación: | 2014 | Editor: | Company of Biologists | Citación: | Disease Models and Mechanisms 7(9): 1093-1100 (2014) | Resumen: | Oxidative stress contributes to the progression of acute liver failure (ALF). Transcription factor nuclear factor-erythroid 2-related factor (Nrf2) serves as an endogenous regulator by which cells combat oxidative stress. We have investigated liver damage and the balance between death and survival signaling pathways in concanavalin A (ConA)-mediated ALF using in vivo siRNA delivery targeting Keap1 in hepatocytes. For that goal, mice were injected with Keap1- or luciferase-siRNA-containing liposomes via the tail vein. After 48 hours, ALF was induced by ConA. Liver histology, proinflammatory mediators, antioxidant responses, cellular death, and stress and survival signaling were assessed. Keap1 mRNA and protein levels significantly decreased in livers of Keap1-siRNAinjected mice. In these animals, histological liver damage was less evident than in control mice when challenged with ConA. Likewise, markers of cellular death (FasL and caspases 8, 3 and 1) decreased at 4 and 8 hours post-injection. Nuclear Nrf2 and its target, hemoxygenase 1 (HO1), were elevated in Keap1-siRNA-injected mice compared with control animals, resulting in reduced oxidative stress in the liver. Similarly, mRNA levels of pro-inflammatory cytokines were reduced in livers from Keap1-siRNA-injected mice. At the molecular level, activation of c-jun (NH2) terminal kinase (JNK) was ameliorated, whereas the insulin-like growth factor I receptor (IGFIR) survival pathway was maintained upon ConA injection in Keap1-siRNA-treated mice. In conclusion, our results have revealed a potential therapeutic use of in vivo siRNA technology targeted to Keap1 to combat oxidative stress by modulating Nrf2-mediated antioxidant responses and IGFIR survival signaling during the progression of ALF. | Descripción: | This is an Open Access article distributed under the terms of the Creative Commons Attribution License. | Versión del editor: | http://dx.doi.org/10.1242/dmm.015537 | URI: | http://hdl.handle.net/10261/124283 | DOI: | 10.1242/dmm.015537 | Identificadores: | doi: 10.1242/dmm.015537 issn: 1754-8403 e-issn: 1754-8411 |
Aparece en las colecciones: | (IIBM) Artículos |
Ficheros en este ítem:
Fichero | Descripción | Tamaño | Formato | |
---|---|---|---|---|
In vivo siRNA.pdf | 1,56 MB | Adobe PDF | Visualizar/Abrir |
CORE Recommender
PubMed Central
Citations
12
checked on 14-abr-2024
SCOPUSTM
Citations
17
checked on 13-abr-2024
WEB OF SCIENCETM
Citations
16
checked on 23-feb-2024
Page view(s)
291
checked on 17-abr-2024
Download(s)
362
checked on 17-abr-2024